Page 300 - Tata_Chemicals_yearly-reports-2020-2021
P. 300

Integrated Annual Report 2020-21




                                      Net Assets i.e. total assets   Share in Profit or Loss  Share in other   Share in total
                                       minus total liabilities           comprehensive income  comprehensive income
            Sr.                                                               As % of            As % of
           No.  Name of the Company       As % of          As % of   ` in   consolidated   ` in   consolidated   ` in
                                      consolidated   ` in crore consolidated   crore  other   crore  total   crore
                                        net assets      profit or loss   comprehensive      comprehensive
                                                                              income             income
            25 Brinefield Storage Limited   (0.00)   (0.06)     -     -            -      -           -     -
            26 Cheshire Cavity Storage 2 Limited   -    *       -     -            -      -           -     -
            27 Cheshire Compressor Limited    -       *         -     -            -      -           -     -
            28 Irish Feeds Limited            -       *         -     -            -      -           -     -
            29 New Cheshire Salt Works Limited   0.06    19.78    0.04    0.25     -      -         0.01    0.25
            30 PT. Metahelix Lifesciences Indonesia   0.00    1.18    (0.02)   (0.10)   -    -     (0.01)   (0.10)
            31 ALCAD                        0.03    9.84    22.71   134.88         -      -         7.80    134.88
                                          100.00   32,807.30   100.00    594.10   100.00   1,135.58   100.00  1,729.68
           a)  Non-controlling Interests
               Indian Subsidiaries
               Rallis India Limited               (851.91)        (112.42)             (0.70)           (113.12)
               Foreign Subsidiaries
               TCSAP Holdings                         -            (67.43)                -              (67.43)
               PT. Metahelix Lifesciences Indonesia   (0.69)          -                   -                 -
                                                 (852.60)         (179.85)             (0.70)           (180.55)
           b)  Joint Ventures
               (Investment as per the Equity
               method)
               JOil (S) Pte. Ltd. and its subsidiaries   -            -                   -                 -
               The Block Salt Company Limited       1.74            (0.67)                -              (0.67)
               Indo Maroc Phosphore S.A.           411.38           84.16                 -               84.16
               Tata Industries Ltd.                538.77          (57.87)            164.17             106.30
                                                  951.89           25.62              164.17            189.79
           c)  Adjustments arising out of       (18,616.62)       (183.50)            116.61             (66.89)
               Consolidation
               Consolidated                     14,289.97        256.37              1,415.66         1,672.03
           *value below ` 50,000/-
           49.  Approval of Consolidated Financial Statements

               These Consolidated Financial Statements were approved for issue by the Board of Directors on May 3, 2021.


           Signatures to notes forming part of the Consolidated Financial Statements 1 - 49



           As per our report of even date attached             For and on behalf of the Board
           For B S R & Co. LLP                                 N. Chandrasekaran    Chairman
           Chartered Accountants                               (DIN: 00121863)      Director
                                                               Padmini Khare Kaicker
           Firm's Registration No: 101248W/W - 100022          (DIN: 00296388)
                                                               R. Mukundan          Managing Director and CEO
           Vijay Mathur                                        (DIN: 00778253)
           Partner                                             Nandakumar S. Tirumalai  Chief Financial Officer
                                                               (ICAI M. No.: 203896)
           Membership No. 046476                               Rajiv Chandan        General Counsel & Company Secretary
           Mumbai, May 3, 2021                                 (ICSI M. No.: FCS 4312)





           298
   295   296   297   298   299   300   301   302   303   304   305